Moderna is a small company just a stone’s throw from The World’s headquarters, in Cambridge, Massachusetts. Until the pandemic, the company was pretty obscure. Now, it has brought the world one of the most powerful tools in this pandemic: a highly effective vaccine against the coronavirus. But Moderna has also been in the global hot seat over its handling of vaccine manufacturing and global access. As The World’s Elana Gordon reports, recent patent disputes and pressure from shareholders are amplifying difficult questions about what this small, New England company really owes the world during a pandemic.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?